Ferrere Abogados has helped biotechnology company Biogen Idec gain an operating licence for multiple sclerosis drug Avonex.
Send a list of links to your own e-mail address, as well as facilitate future revisions of the corresponding information.
Save a PDF copy on your computer to save the selected content in your files and / or read it in a printed version.
Completely anonymous. We will not save the email address or use it for our communications.